Search

for
Search:

Glossary Warfarin

blood thinner that prevents clot formation by inhibiting vitamin K

Warfarin, also known by brand names such as Coumadin, is an anticoagulant or blood thinner. It works by inhibiting the synthesis of vitamin K-dependent clotting factors, which are essential for blood clot formation. This medication is commonly prescribed to prevent blood clots in conditions like atrial fibrillation, deep vein thrombosis, and pulmonary embolism.

Research

5 / 308 results

research Warfarin: almost 60 years old and still causing problems

322 citations , October 2006 in “British Journal of Clinical Pharmacology”

This article reviews the history and challenges of warfarin use and suggests that monitoring genetic and environmental factors could improve individualized dosing and safety, but no new results are reported.

research WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT

1 citations , September 2017 in “Asian Journal of Pharmaceutical and Clinical Research”

This case report documents warfarin-induced alopecia in a 39-year-old male in Southern India, adding to the limited case reports on this potential side effect.

research WARFARIN

February 2010

This article reviews potential drug and herbal interactions with warfarin that may increase bleeding risk, and reports no new clinical results.

research Pseudoxanthoma Elasticum: Progress in Research Toward Treatment: Summary of the 2012 PXE International Research Meeting

46 citations , May 2013 in “The journal of investigative dermatology/Journal of investigative dermatology”

This review discusses the state-of-the-art knowledge on pseudoxanthoma elasticum, summarizing recent advancements in genetics, pathomechanisms, and potential treatments but reports no new clinical findings.

research Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature

31 citations , January 2016 in “Drugs - Real World Outcomes”

This review discusses the potential link between direct oral anticoagulants and hair loss, suggesting DOACs may not be a suitable alternative for patients with alopecia from traditional anticoagulants; however, no clinical results are reported.

View more "warfarin" in research →

Learn

— no results

Try a deeper search in learn →

Community Join

— no results

Experts

— no results

Try a deeper search in experts →

Clinics

— no results

Try a deeper search in clinics →